These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7193534)

  • 1. A peculiar toxicity manifested by platinum(II)amines in rats: gastric distension after intraperitoneal administration.
    Roos IA; Fairlie DP; Whitehouse MW
    Chem Biol Interact; 1981 Apr; 35(1):111-7. PubMed ID: 7193534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in rats.
    Broomhead JA; Fairlie DP; Whitehouse MW
    Chem Biol Interact; 1980 Jul; 31(1):113-32. PubMed ID: 7190079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of metoclopramide on gastric distension and lethal toxicity of cisplatin in mice].
    Lee KE; Kubota T; Sawamura M; Kadowaki K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1911-4. PubMed ID: 3707151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metaclopramide for preventing watery mouth.
    Stewart M
    Vet Rec; 1989 May; 124(18):497-8. PubMed ID: 2750039
    [No Abstract]   [Full Text] [Related]  

  • 6. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica.
    Cabezos PA; Vera G; Martín-Fontelles MI; Fernández-Pujol R; Abalo R
    Neurogastroenterol Motil; 2010 Jul; 22(7):797-805, e224-5. PubMed ID: 20236245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric distension following ketamine.
    Thompson MC
    Anaesthesia; 1984 Nov; 39(11):1151-2. PubMed ID: 6507842
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of central oxytocin in the inhibition by endotoxin of distension-stimulated gastric acid secretion.
    Calatayud S; Quintana E; Esplugues J; Barrachina MD
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):676-82. PubMed ID: 10619185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres.
    Kumagai S; Sugiyama T; Nishida T; Ushijima K; Yakushiji M
    Jpn J Cancer Res; 1996 Apr; 87(4):412-7. PubMed ID: 8641974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal cisplatin with sodium thiosulfate protection in rats with intestinal anastomoses.
    Wile AG; Dileo SK; Gossett DA; Lao XY
    J Surg Oncol; 1993 Apr; 52(4):265-8. PubMed ID: 8468990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
    Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
    Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
    Härtl A; Güttner J; Horn U; Jelinek F; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):239-44. PubMed ID: 2640563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To determine the effect of metoclopramide on gastric emptying in severe head injuries: a prospective, randomized, controlled clinical trial.
    Marino LV; Kiratu EM; French S; Nathoo N
    Br J Neurosurg; 2003 Feb; 17(1):24-8. PubMed ID: 12779198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.
    Sarici SU; Yurdakök M; Unal S
    Pediatr Radiol; 2001 Aug; 31(8):581-3. PubMed ID: 11550771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats].
    Horn U; Härtl A; Neuhaus G; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):245-50. PubMed ID: 2802932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.
    McKeage MJ; Boxall FE; Jones M; Harrap KR
    Cancer Res; 1994 Feb; 54(3):629-31. PubMed ID: 8306321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats.
    Zicca A; Cafaggi S; Mariggiò MA; Vannozzi MO; Ottone M; Bocchini V; Caviglioli G; Viale M
    Eur J Pharmacol; 2002 May; 442(3):265-72. PubMed ID: 12065080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.